Ibritumomab Intravenous and Letermovir
Determining the interaction of Ibritumomab Intravenous and Letermovir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: letermovir
Brand name: Prevymis
Synonyms: Letermovir (Oral), Letermovir (oral/injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Letermovir Injection
- Ibritumomab Intravenous-Letermovir Intravenous
- Ibritumomab Intravenous-Letermovir oral/injection
- Ibritumomab Intravenous-Letermovir Tablets
- Ibritumomab Intravenous-Letrozole
- Ibritumomab Intravenous-Letrozole and ribociclib
- Letermovir-Ibritumomab Tiuxetan
- Letermovir-Ibrutinib
- Letermovir-Ibrutinib Capsules
- Letermovir-Ibrutinib Tablets
- Letermovir-Ibu
- Letermovir-IBU Tablets